LGBTQ patients have unique risk factors for cancer and oncologists admit they don’t know enough about them, a new national survey reveals.
I am blessed with healthy children, but through my husband, the hospital clown, dozens of seriously ill children have left
There is a raging debate going on in Washington about how the government pays for drugs used to treat cancer, rheumatoid arthritis, immunodeficiency diseases, and other serious medical conditions.
Although the process can be both difficult and rewarding, people can find help in relieving the emotional impact of cancer by applying simple, yet scientifically proven, strategies: Reimagine helped me do some of that.
A life dominated by mouth cancer, the biblical writers have shown me that God is big enough to take it when we shout, "Why are you sleeping in my storm?" In the case of the disciples, Jesus responds by stilling the wind with the same language he used to cast out demons.
It's time to give interventional oncologists the attention and recognition they deserve for improving the lives of cancer patients.
I hope to return to the lab after this year and try to understand why immunotherapy is lifesaving for some patients like President Carter, while others like Mrs. B remain lost in a biological dark matter. Above all else, I am drawn to the opportunity to fight in her corner once more.
To some extent, this debunks the implied merits of the-greater-the-force-the-better propaganda. Such is the stuff of campaign
Entrepreneurs' braggadocio has long been an item of parody, but their claims to "make the world a better place by disrupting (insert jargon)" highlight a deep-rooted problem in the world of innovation.
Recent studies have shown that doctors may be overdiagnosing, and overtreating, some types of cancer.
We need to refocus our resources and attention on the two things that really matter: (1) stopping men and women from getting breast cancer in the first place -- primary prevention; and (2) preventing metastasis if they do.